Literature DB >> 27021778

Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation.

Maria R Almeida1, Maria C Macário2, Lina Ramos3, Inês Baldeiras4, Maria H Ribeiro4, Isabel Santana5.   

Abstract

We and others have reported heterozygous progranulin mutations as an important cause of frontotemporal lobar degeneration (FTLD). It has been identified a complete progranulin deficiency because of a homozygous mutation in a sibling pair with neuronal ceroid lipofuscinosis (NCL). Here, we describe the first case of NCL caused by a homozygous progranulin mutation segregating in a family with neuropathological confirmed FTLD. In this FTLD-NCL family, we detail the clinical phenotype, neuropsychological evaluation and imaging data of our proband harboring a homozygous mutation, c.900_901dupGT, with serum progranulin level (<6 ng/mL). Symptoms included rapidly progressive visual deficit, slightly dysarthria, and cerebellar ataxia. The electroretinogram confirmed a severe attenuation of rod and cone responses compatible with retinal dystrophy diagnosis and magnetic resonance imaging showed severe global cerebellar atrophy. In contrast, heterozygous relatives presented behavioral variant of frontotemporal dementia (FTD) and some also developed extrapyramidal features compatible with corticobasal syndrome. Our findings suggest the importance of assessing serum progranulin levels in suspected recessive adult-onset NCL cases. Overall, a more holistic neurologic intervention is needed to guarantee a proper genetic counseling in cases like the present family where two distinct phenotypes are generated according to the individuals' mutation state.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FTLD-NCL family; Frontotemporal lobar degeneration; Homozygous or heterozygous state; Neuronal ceroid lipofuscinosis; Progranulin mutation

Mesh:

Substances:

Year:  2016        PMID: 27021778     DOI: 10.1016/j.neurobiolaging.2016.02.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  48 in total

1.  Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis.

Authors:  Michael E Ward; Robert Chen; Hsin-Yi Huang; Connor Ludwig; Maria Telpoukhovskaia; Ali Taubes; Helene Boudin; Sakura S Minami; Meredith Reichert; Philipp Albrecht; Jeffrey M Gelfand; Andres Cruz-Herranz; Christian Cordano; Marcel V Alavi; Shannon Leslie; William W Seeley; Bruce L Miller; Eileen Bigio; Marek-Marsel Mesulam; Matthew S Bogyo; Ian R Mackenzie; John F Staropoli; Susan L Cotman; Eric J Huang; Li Gan; Ari J Green
Journal:  Sci Transl Med       Date:  2017-04-12       Impact factor: 17.956

2.  Progranulin in the hematopoietic compartment protects mice from atherosclerosis.

Authors:  Andrew D Nguyen; Thi A Nguyen; Rajesh K Singh; Delphine Eberlé; Jiasheng Zhang; Jess Porter Abate; Anatalia Robles; Suneil Koliwad; Eric J Huang; Frederick R Maxfield; Tobias C Walther; Robert V Farese
Journal:  Atherosclerosis       Date:  2018-08-30       Impact factor: 5.162

3.  Regulation of cathepsin D activity by the FTLD protein progranulin.

Authors:  Xiaolai Zhou; Daniel H Paushter; Tuancheng Feng; Cara M Pardon; Christina S Mendoza; Fenghua Hu
Journal:  Acta Neuropathol       Date:  2017-05-10       Impact factor: 17.088

4.  AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.

Authors:  Defne A Amado; Julianne M Rieders; Fortunay Diatta; Pilar Hernandez-Con; Adina Singer; Jordan T Mak; Junxian Zhang; Eric Lancaster; Beverly L Davidson; Alice S Chen-Plotkin
Journal:  Mol Ther       Date:  2018-11-17       Impact factor: 11.454

5.  Reduction of microglial progranulin does not exacerbate pathology or behavioral deficits in neuronal progranulin-insufficient mice.

Authors:  Andrew E Arrant; Anthony J Filiano; Aashka R Patel; Madelyn Q Hoffmann; Nicholas R Boyle; Shreya N Kashyap; Vincent C Onyilo; Allen H Young; Erik D Roberson
Journal:  Neurobiol Dis       Date:  2018-11-15       Impact factor: 5.996

6.  Progranulin mutations result in impaired processing of prosaposin and reduced glucocerebrosidase activity.

Authors:  Clarissa Valdez; Daniel Ysselstein; Tiffany J Young; Jianbin Zheng; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

7.  Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients.

Authors:  Clarissa Valdez; Yvette C Wong; Michael Schwake; Guojun Bu; Zbigniew K Wszolek; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2017-12-15       Impact factor: 6.150

Review 8.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

Review 9.  RNA Binding Proteins and the Pathogenesis of Frontotemporal Lobar Degeneration.

Authors:  Jeffrey W Hofmann; William W Seeley; Eric J Huang
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

10.  Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.

Authors:  Andrew E Arrant; Vincent C Onyilo; Daniel E Unger; Erik D Roberson
Journal:  J Neurosci       Date:  2018-01-29       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.